126448-27-9 Usage
Uses
Used in Pharmaceutical Industry:
[1,2,5]Oxadiazolo[3,4-b]quinoxaline,1,3-dihydro-(9CI) is used as a potential pharmaceutical compound for its demonstrated biological activity. The specific application and use of [1,2,5]Oxadiazolo[3,4-b]quinoxaline,1,3-dihydro-(9CI) will depend on the context of the research and its potential therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 126448-27-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,4,4 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 126448-27:
(8*1)+(7*2)+(6*6)+(5*4)+(4*4)+(3*8)+(2*2)+(1*7)=129
129 % 10 = 9
So 126448-27-9 is a valid CAS Registry Number.
126448-27-9Relevant academic research and scientific papers
Reactions of Furazanoquinoxalines with Phosphorus Ylides and an Unusual Oxidative Transformation of the Transylidation Product
Gallos, John K.,Lianis, Pygmalion S.,Nicolaides, Demetrios N.
, p. 1415 - 1420 (2007/10/02)
Reactions of furazanoquinoxalines 1 with phosphorus ylides 2 afford the transylidation product 3 and/or 4,9-dihydrofurazanoquinoxalines 4.Oxidation of 3 with phenyliodide bis-trifluoroacetate gave the fused furan derivative 13 in high yield.
